117 related articles for article (PubMed ID: 643153)
1. [Cerebrospinal fluid amine metabolites and L-dopa in vegetative state patients (author's transl)].
Inagawa T; Ishikawa S; Uozumi T
No Shinkei Geka; 1978 Mar; 6(3):235-43. PubMed ID: 643153
[No Abstract] [Full Text] [Related]
2. [Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in the patients with epilepsy (author's transl)].
Nagao T; Fujimoto A; Ohshimo T; Yamamoto M; Kugoh T; Akiyama K; Otsuki S
No To Shinkei; 1979 Dec; 31(12):1225-31. PubMed ID: 93481
[No Abstract] [Full Text] [Related]
3. Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy.
Korf J; van Praag HM; Schut D; Nienhuis RJ; Lakke JP
Eur Neurol; 1974; 12(5-6):340-50. PubMed ID: 4448192
[No Abstract] [Full Text] [Related]
4. [Homovanillic acid and 5--hydroxy-indoleacetic acid in the cerebrospinal fluid of man--concentration gradients between lumbar and ventricular CSF and variations in ventricular CSF-- (author's transl)].
Inagawa T; Kajihara S; Okada Y; Yoshimoto H; Mori S; Ishikawa S; Uozumi T
No To Shinkei; 1978 May; 30(5):565-74. PubMed ID: 666924
[No Abstract] [Full Text] [Related]
5. Homovanillic acid and 5-hydroxyindoleacetic acid in lumbar cerebrospinal fluid of patients with acute cerebrovascular lesion.
Livrea P; Papagno G; Di Reda L; Centrone G
Acta Neurol (Napoli); 1976; 31(5):647-51. PubMed ID: 1015387
[No Abstract] [Full Text] [Related]
6. [The monamine metabolites in the CSF of the patients with spinocerebellar degeneration and motor neuron disease (author's transl)].
Yamamoto M
Rinsho Shinkeigaku; 1980 Jul; 20(7):503-9. PubMed ID: 6161732
[No Abstract] [Full Text] [Related]
7. Parallel variation of homovanillic acid and 5-hydroxyindoleacetic acid in ventricular cerebrospinal fluid of man.
Inagawa T; Mori S; Yoshimoto H; Ishikawa S; Uozumi T
Hiroshima J Med Sci; 1976 Sep; 25(2-3):79-87. PubMed ID: 1026667
[No Abstract] [Full Text] [Related]
8. The effects of reserpine, L-dopa and 5-hydroxytryptophan on 5-hydroxyindoleacetic and homovanillic acids in cerebrospinal fluid, behaviour and EEG in cats.
Buckingham RL; Radulovacki M
Neuropharmacology; 1976 Jul; 15(7):389-92. PubMed ID: 1086441
[No Abstract] [Full Text] [Related]
9. Effect of ischemia on monoamine metabolism. Brain monoamine metabolites in cerebrospinal fluid of patients with recent cerebral infarction.
Stelmasiak Z
Neuropatol Pol; 1982; 20(1-2):97-105. PubMed ID: 6191248
[No Abstract] [Full Text] [Related]
10. [5-HIAA and HVA levels in the cerebrospinal fluid of hydrocephalic patients].
Massarotti M; Migliore A; Roccella P; Toffano G
Acta Neurol (Napoli); 1976; 31(5):601-13. PubMed ID: 1015383
[No Abstract] [Full Text] [Related]
11. Treatment of non-fluctuating progressive dystonia: a neuropharmacological approach.
Willemse J; van Nieuwenhuizen O; Gooskens RH; Westenberg HG
Neuropediatrics; 1984 Oct; 15(4):208-10. PubMed ID: 6208504
[TBL] [Abstract][Full Text] [Related]
12. Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.
Campanella G; Algeri S; Cerletti C; Dolfini E; Jori A; Rinaldi F
Eur J Clin Pharmacol; 1977 Apr; 11(4):255-61. PubMed ID: 862646
[No Abstract] [Full Text] [Related]
13. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) levels in the lumbar cerebrospinal fluid in epileptic patients].
Livrea P; Di Reda L; Puca FM; Genco S; Specchio L; Papagno G
Boll Soc Ital Biol Sper; 1976 Jun; 52(11):800-5. PubMed ID: 1016632
[No Abstract] [Full Text] [Related]
14. Parallel variation of homovanillic acid, 5-hydroxyindoleacetic acid and cyclic adenosine-3, 5-monophosphate in ventricular cerebrospinal fluid of man.
Inagawa T
Hiroshima J Med Sci; 1982 Jun; 31(2):117-21. PubMed ID: 6182129
[No Abstract] [Full Text] [Related]
15. Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.
Gumpert J; Sharpe D; Curzon G
J Neurol Sci; 1973 May; 19(1):1-12. PubMed ID: 4715017
[No Abstract] [Full Text] [Related]
16. Gradients of biogenic amine metabolites in cerebrospinal fluid.
Siever L; Kraemer H; Sack R; Angwin P; Berger P; Zarcone V; Barchas J; Brodie HK
Dis Nerv Syst; 1975 Jan; 36(1):13-6. PubMed ID: 1109880
[No Abstract] [Full Text] [Related]
17. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
Seifert WE; Foxx JL; Butler IJ
Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
[TBL] [Abstract][Full Text] [Related]
18. Acidic metabolites of dopamine and serotonin in cerebrospinal fluid.
Sourkes TL
Adv Neurol; 1974; 5():271-3. PubMed ID: 4440576
[No Abstract] [Full Text] [Related]
19. Overnight sleep EEG and cerebrospinal fluid monoamines in seizures induced by movement.
Fukuyama Y; Ochiai Y; Hayakawa T; Miyagawa F
Neuropadiatrie; 1979 May; 10(2):138-49. PubMed ID: 226908
[TBL] [Abstract][Full Text] [Related]
20. [Cerebrospinal HVA and 5-HIAA in patients with endogenous depression in the course of treatment].
Loeb DC; Roccatagliata G; Albano C; Abbruzzese G
Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):27-32. PubMed ID: 6158092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
